within Pharmacolibrary.Drugs.N_NervousSystem.N06A_Antidepressants.N06AX09_Viloxazine;

model Viloxazine
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_1C_enteral(
    weight = 70,
    F = 0.88,
    Cl = 2.5666666666666666e-05,
    adminDuration = 600,
    adminMass = 700 / 1000000,
    adminCount = 1,
    Vd = 0.0076,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    ka = 0.018333333333333333,
    Tlag = 10.020000000000001);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Viloxazine</td></tr><tr><td>ATC code:</td><td>N06AX09</td></tr><td>route:</td><td>oral</td></tr>
    <tr><td>compartments:</td><td>1</td></tr>
    <tr><td>dosage:</td><td>700</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>7.6</td><td>L</td></tr>
    <tr><td>clearance:</td><td>1.32</td><td>L/h/kg</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Viloxazine is a selective norepinephrine reuptake inhibitor that was originally developed and used as an antidepressant in several European countries. It is now approved by the US FDA as a non-stimulant treatment for attention-deficit/hyperactivity disorder (ADHD) in children and adolescents.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adults after single oral administration.</p><h4>References</h4><ol><li><p>De Hondt, L, et al., &amp; Tommelein, E (2024). Quantification of ADHD medication in biological fluids of pregnant and breastfeeding women with liquid chromatography: a comprehensive review. <i>Frontiers in public health</i> 12 1437328–None. DOI:<a href=\"https://doi.org/10.3389/fpubh.2024.1437328\">10.3389/fpubh.2024.1437328</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/39171321/\">https://pubmed.ncbi.nlm.nih.gov/39171321</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.N.N06AX09 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Viloxazine;
